Table 1. Baseline patient clinical characteristics for all patients.
| Characteristic | CCRT+hysterectomy (n=34) | Only CCRT (n=21) | p-value* |
|---|---|---|---|
| Age (yr) | 46.5 (39.75-54.25) | 49 (40.5-59.5) | 0.25 |
| Size (cm) | 0.17 | ||
| ≥4 | 18 (52.9) | 15 (71.4) | |
| <4 | 16 (47.1) | 6 (28.6) | |
| Grade | 0.56 | ||
| 1 | 13 (38.2) | 6 (28.6) | |
| 2 | 13 (38.2) | 7 (33.3) | |
| 3 | 4 (11.8) | 5 (23.8) | |
| Undefined | 4 (11.8) | 3 (14.3) | |
| Stage | 0.16 | ||
| IB2 | 3 (8.8) | 1 (4.8) | |
| IIA | 4 (11.8) | 1 (4.8) | |
| IIB | 24 (70.6) | 15 (71.4) | |
| III | 3 (8.8) | 4 (19) | |
| Pregnancy | 3 (2-4) | 2 (1-3) | 0.83 |
| Delivery | 1 (1-1) | 1 (1-2) | 0.96 |
| CA-125 elevation (%) | 14 (41.2) | 12 (57.1) | 0.25 |
| Lymphadenopathy (%) | 10 (29.4) | 7 (33.3) | 0.76 |
| Chemo before CCRT (%) | 23 (67.7) | 13 (61.9) | 0.66 |
| CR after CCRT | 18 (52.9) | 10 (47.6) | 0.93 |
Values are presented as median (interquartile range) or number (%).
CA-125, cancer antigen 125; CCRT, concurrent chemoradiotherapy; CR, complete remission.
*Fisher exact test for qualitative variables and Mann-Whitney U-test for quantitative variables.